Close Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.33M | Sell |
31,032
-662
| -2% | -$92.7K | 0.12% | 55 |
|
|
2025
Q4 | $3.89M | Sell |
31,694
-145
| -0.5% | -$17.6K | 0.09% | 59 |
|
|
2025
Q3 | $3.53M | Sell |
31,839
-1,179
| -4% | -$134K | 0.08% | 61 |
|
|
2025
Q2 | $3.66M | Sell |
33,018
-90
| -0.3% | -$9.58K | 0.11% | 61 |
|
|
2025
Q1 | $3.71M | Sell |
33,108
-720
| -2% | -$74.3K | 0.11% | 59 |
|
|
2024
Q4 | $3.12M | Hold |
33,828
| – | – | 0.09% | 57 |
|
|
2024
Q3 | $2.84M | Sell |
33,828
-180
| -0.5% | -$13.7K | 0.09% | 59 |
|
|
2024
Q2 | $2.33M | Buy |
34,008
+154
| +0.5% | +$10.3K | 0.08% | 62 |
|
|
2024
Q1 | $2.48M | Sell |
33,854
-310
| -0.9% | -$23.8K | 0.09% | 61 |
|
|
2023
Q4 | $2.77M | Buy |
34,164
+155
| +0.5% | +$12.1K | 0.12% | 56 |
|
|
2023
Q3 | $2.55M | Buy |
34,009
+520
| +2% | +$40K | 0.13% | 60 |
|
|
2023
Q2 | $2.58M | Buy |
33,489
+1,460
| +5% | +$116K | 0.12% | 57 |
|
|
2023
Q1 | $2.66M | Sell |
32,029
-3,220
| -9% | -$267K | 0.13% | 54 |
|
|
2022
Q4 | $3.03M | Sell |
35,249
-1,035
| -3% | -$82K | 0.16% | 49 |
|
|
2022
Q3 | $2.24M | Buy |
36,284
+1,273
| +4% | +$80.3K | 0.13% | 48 |
|
|
2022
Q2 | $2.17M | Buy |
35,011
+614
| +2% | +$38K | 0.1% | 52 |
|
|
2022
Q1 | $2.5M | Hold |
34,397
| – | – | 0.09% | 50 |
|
|
2021
Q4 | $2.5M | Sell |
34,397
-633
| -2% | -$43.6K | 0.09% | 50 |
|
|
2021
Q3 | $2.45M | Buy |
35,030
+1,600
| +5% | +$112K | 0.12% | 48 |
|
|
2021
Q2 | $2.3M | Buy |
33,430
+3,100
| +10% | +$207K | 0.11% | 50 |
|
|
2021
Q1 | $1.96M | Buy |
30,330
+1,753
| +6% | +$113K | 0.1% | 59 |
|
|
2020
Q4 | $1.66M | Buy |
28,577
+9,025
| +46% | +$545K | 0.12% | 47 |
|
|
2020
Q3 | $1.24M | Buy |
19,552
+8,120
| +71% | +$563K | 0.08% | 51 |
|
|
2020
Q2 | $880K | Buy |
11,432
+2,057
| +22% | +$158K | 0.07% | 55 |
|
|
2020
Q1 | $701K | Buy |
9,375
+375
| +4% | +$25.9K | 0.06% | 57 |
|
|
2019
Q4 | $585K | Buy |
9,000
+350
| +4% | +$22.8K | 0.05% | 64 |
|
|
2019
Q3 | $548K | Buy |
8,650
+450
| +5% | +$29.4K | 0.05% | 67 |
|
|
2019
Q2 | $554K | Buy |
8,200
+5,170
| +171% | +$340K | 0.04% | 66 |
|
|
2019
Q1 | $197K | Buy |
3,030
+2,915
| +2,535% | +$194K | 0.02% | 94 |
|
|
2018
Q4 | $11K | Sell |
115
-8,085
| -99% | -$565K | ﹤0.01% | 156 |
|
|
2018
Q3 | $324K | Sell |
8,200
-250
| -3% | -$18.9K | 0.03% | 81 |
|
|
2018
Q2 | $618K | Hold |
8,450
| – | – | 0.05% | 66 |
|
|
2018
Q1 | $618K | Sell |
8,450
-50
| -0.6% | -$3.98K | 0.05% | 67 |
|
|
2017
Q4 | $609K | Hold |
8,500
| – | – | 0.05% | 66 |
|
|
2017
Q3 | $689K | Buy |
8,500
+500
| +6% | +$38.2K | 0.07% | 66 |
|
|
2017
Q2 | $566K | Buy |
8,000
+3,500
| +78% | +$233K | 0.06% | 69 |
|
|
2017
Q1 | $306K | Buy |
4,500
+3,150
| +233% | +$222K | 0.03% | 79 |
|
|
2016
Q4 | $97K | Buy |
+1,350
| New | +$100K | 0.01% | 85 |
|
Other funds holding GILD
VCM
VPM
Close Asset Management's GILD Position: Q1 2026 in Review
Close Asset Management reduced its Gilead Sciences (GILD) stake by 2.1% in Q1 2026, selling an estimated $92.7K and leaving 31,032 shares worth $4.33M. The position accounts for 0.12% of the portfolio, ranked #55.
Close Asset Management first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Close Asset Management held 31,032 shares of Gilead Sciences worth $4.33M as of Q1 2026.
- Close Asset Management sold 662 Gilead Sciences shares in Q1 2026, an estimated $92.7K.
- Gilead Sciences made up 0.12% of Close Asset Management's portfolio in Q1 2026, its #55 holding.
- Close Asset Management first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.